Drug-Eluting Stents Promise Limited Applicability, High Cost – Clinicians

Hospitals stand to draw up to 40% less income from stenting procedures using drug-eluting stents instead of their bare metal predecessors, according to Louis Cannon, MD, Michigan Cardiovascular Institute

More from Archive

More from Medtech Insight